IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge

PRINCETON, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the launch of its global medical education platform . This new digital resource is designed to elevate Integra’s medical education offerings in surgical, neurologic, ENT and regenerative care​ by enhancing professional development through a wealth of on-demand learning resources.

The Integra Institute platform is designed for healthcare providers (HCPs) in the United States and EMEA across multiple medical specialties, tailored to a variety of experience levels. The curated hub includes on-demand webinars on complex medical scenarios​, surgical videos showcasing the latest techniques and best practices​ and an events calendar for continuous learning and networking.

“Integra is a longstanding partner to HCPs who work on complex procedures with a profound impact on patients’ lives. We are proud to build on our strong partnerships with this community by developing a premier, one-stop-shop in professional education,” said Kristen Hedstrom, Integra’s vice president of professional education and divisional market access.

“HCPs often look for efficient, digital tools to stay up to date with the latest guidance in our fields and advance patient outcomes. I am excited about the Integra Institute and its facilitation of convenient learning and collaboration across the industry,” said Dr. Said Azoury, plastic and reconstructive surgeon and assistant professor of surgery at the Hospital of the University of Pennsylvania.

Interested clinicians can explore the site by registering for an account at: .

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit

Contacts:

Media

Laurene Isip



Investor Relations

Chris Ward





EN
14/01/2025

Underlying

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE

Integra LifeSciences Launches Integra Institute for Healthcare Profess...

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge PRINCETON, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the launch of its global medical education platform . This new digital resource is designed to elevate Integra’s medical education offerings in surgical, neurologic, ENT and regenerative care​ by enhancing professional development through a wealth of on-demand learning ...

 PRESS RELEASE

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to ...

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue PRINCETON, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the publication of a new economic study, “PEG hydrogel sealant versus fibrin g...

 PRESS RELEASE

Integra LifeSciences Reports Third Quarter 2024 Financial Results

Integra LifeSciences Reports Third Quarter 2024 Financial Results PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Highlights Third quarter revenues of $380.8 million decreased 0.4% on a reported basis and 8.6% on an organic basis compared to the prior year. Revenue decreased 10.3% on an organic basis excluding Boston.Third quarter GAAP earnings per diluted share of $(0.14), compared to $0.24 in the prior year; adjusted ...

 PRESS RELEASE

Integra LifeSciences Announces Appointment of Mojdeh Poul as President...

Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:IART), a leading global medical technology company, today announced that its board of directors has appointed Mojdeh Poul as the new president and chief executive officer, effective January 6, 2025. Ms. Poul wil...

 PRESS RELEASE

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conf...

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch